Lifevantage Corporation (NASDAQ:LFVN) — Market Cap & Net Worth
Market Cap & Net Worth: Lifevantage Corporation (LFVN)
Lifevantage Corporation (NASDAQ:LFVN) has a market capitalization of $64.35 Million ($64.35 Million) as of May 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #20905 globally and #4481 in its home market, demonstrating a 9.48% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Lifevantage Corporation's stock price $5.43 by its total outstanding shares 12793359 (12.79 Million). Analyse LFVN cash generation efficiency to see how efficiently the company converts income to cash.
Lifevantage Corporation Market Cap History: 2015 to 2026
Lifevantage Corporation's market capitalization history from 2015 to 2026. Data shows growth from $108.44 Million to $69.47 Million (0.64% CAGR).
Index Memberships
Lifevantage Corporation is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Composite
IXIC
|
$38.77 Trillion | 0.00% | #2020 of 3165 |
Weight: Lifevantage Corporation's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Lifevantage Corporation Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Lifevantage Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.34x
Lifevantage Corporation's market cap is 0.34 times its annual revenue
Latest Price to Earnings (P/E) Ratio
8.04x
Lifevantage Corporation's market cap is 8.04 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $92.84 Million | $206.54 Million | $6.02 Million | 0.45x | 15.42x |
| 2017 | $54.22 Million | $199.49 Million | $1.61 Million | 0.27x | 33.72x |
| 2018 | $150.24 Million | $203.20 Million | $5.76 Million | 0.74x | 26.08x |
| 2019 | $177.81 Million | $225.96 Million | $7.43 Million | 0.79x | 23.93x |
| 2020 | $106.16 Million | $232.91 Million | $11.55 Million | 0.46x | 9.19x |
| 2021 | $71.99 Million | $220.18 Million | $12.89 Million | 0.33x | 5.58x |
| 2022 | $43.30 Million | $206.36 Million | $3.12 Million | 0.21x | 13.88x |
| 2023 | $75.66 Million | $213.40 Million | $2.54 Million | 0.35x | 29.79x |
| 2024 | $224.27 Million | $200.16 Million | $2.94 Million | 1.12x | 76.36x |
| 2025 | $78.81 Million | $228.53 Million | $9.80 Million | 0.34x | 8.04x |
Competitor Companies of LFVN by Market Capitalization
Companies near Lifevantage Corporation in the global market cap rankings as of May 4, 2026.
Key companies related to Lifevantage Corporation by market ranking:
- Nestlé S.A (F:NESM): Ranked #84 globally with a market cap of $224.33 Billion USD ( €191.89 Billion EUR).
- Nestle S.A. (SW:NESN): Ranked #98 globally with a market cap of $203.05 Billion USD ( CHF160.61 Billion CHF).
- Danone SA (PA:BN): Ranked #527 globally with a market cap of $50.25 Billion USD ( €42.98 Billion EUR).
- Danone SA (F:BSND): Ranked #622 globally with a market cap of $42.57 Billion USD ( €36.41 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #84 | Nestlé S.A | F:NESM | $224.33 Billion | €85.60 |
| #98 | Nestle S.A. | SW:NESN | $203.05 Billion | CHF79.05 |
| #527 | Danone SA | PA:BN | $50.25 Billion | €66.74 |
| #622 | Danone SA | F:BSND | $42.57 Billion | €12.70 |
Lifevantage Corporation Historical Marketcap From 2015 to 2026
Between 2015 and today, Lifevantage Corporation's market cap moved from $108.44 Million to $ 69.47 Million, with a yearly change of 0.64%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $69.47 Million | -11.85% |
| 2025 | $78.81 Million | -64.86% |
| 2024 | $224.27 Million | +196.40% |
| 2023 | $75.66 Million | +74.75% |
| 2022 | $43.30 Million | -39.85% |
| 2021 | $71.99 Million | -32.19% |
| 2020 | $106.16 Million | -40.29% |
| 2019 | $177.81 Million | +18.35% |
| 2018 | $150.24 Million | +177.10% |
| 2017 | $54.22 Million | -41.60% |
| 2016 | $92.84 Million | -14.39% |
| 2015 | $108.44 Million | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of Lifevantage Corporation was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $64.35 Million USD |
| MoneyControl | $64.35 Million USD |
| MarketWatch | $64.35 Million USD |
| marketcap.company | $64.35 Million USD |
| Reuters | $64.35 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Lifevantage Corporation
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, pre and pro-biotics and skin and hair care products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 and Omega-7 fatty acids, and vitamin D3… Read more